Fig. 3From: Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in JapanOverall survival (OS) of patients with different subtypes of RAS/BRAFV600E mutations. Analysis of hazard ratio of OS based on RAS/BRAFV600E mutation status in patients with colorectal cancer using Cox regression analysis (N = 152). P-value: Log-rank analysisBack to article page